Literature DB >> 19409566

Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study.

Inga Thorsen Vengen1, Ane Cecilie Dale, Rune Wiseth, Kristian Midthjell, Vibeke Videm.   

Abstract

AIMS: Neopterin has emerged as a novel predictor of coronary events. The study aim was to compare the predictive value of neopterin and C-reactive protein (CRP) on long-term risk for fatal ischemic heart disease (IHD) in persons with newly diagnosed diabetes compared to persons without diabetes. METHODS AND
RESULTS: In 1984-1986 a large population study, HUNT 1, was conducted in Norway. During the study, 205 patients were diagnosed with formerly unknown diabetes. A matched control group without diabetes was selected from the HUNT 1 population. Fatal IHD was registered until 2004. Blood samples were drawn at baseline and serum was analysed for neopterin and CRP. Cox regression analysis with correction for age, gender, hypertension, body mass index, established cardiovascular disease and total cholesterol was used to estimate hazard ratios (HR) for fatal IHD. In the diabetes group, neopterin and CRP were independent predictors of fatal IHD, HR 2.59 (1.11-6.01) and 2.45 (1.05-5.69), respectively. Neither CRP nor neopterin were significant predictors of fatal IHD in the control group.
CONCLUSION: In subjects with diabetes, both neopterin and CRP were independent predictors of fatal IHD, suggesting that these two markers reflect different aspects of the pathogenesis underlying fatal coronary events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409566     DOI: 10.1016/j.atherosclerosis.2009.04.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

Review 2.  Neopterin as a biomarker of immune response in cancer patients.

Authors:  Bohuslav Melichar; Martina Spisarová; Marie Bartoušková; Lenka Kujovská Krčmová; Lenka Javorská; Hana Študentová
Journal:  Ann Transl Med       Date:  2017-07

3.  The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents.

Authors:  Srinivasa Nageswara Rao G; Prema Gurumurthy; Sruti E; K M Cherian
Journal:  J Clin Diagn Res       Date:  2013-04-01

4.  Serum neopterin is not increased in obese juveniles.

Authors:  Harald Mangge; Florian Freytag; Gunter Almer; Daniel Weghuber; Carmen Bauer-Denk; Dietmar Fuchs
Journal:  J Obes       Date:  2011-01-12

5.  Potential Prognostic Role of Immune System Activation Marker Neopterin in Patients with Type 2 Diabetes.

Authors:  Songül Ünüvar; Zübeyde Tanrıverdi; Hamza Aslanhan
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

6.  Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients.

Authors:  Hege Pihlstrøm; Geir Mjøen; Winfried März; Dag Olav Dahle; Sadollah Abedini; Ingar Holme; Bengt Fellström; Alan Jardine; Stefan Pilz; Hallvard Holdaaas
Journal:  Clin Transplant       Date:  2013-12-24       Impact factor: 2.863

7.  Inflammatory markers and risk of cardiovascular mortality in relation to diabetes status in the HUNT study.

Authors:  Lena Løfblad; Gunhild Garmo Hov; Arne Åsberg; Vibeke Videm
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

8.  Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes.

Authors:  Long-Yi Zheng; Jin Lu; Ren-Hui Wan; Yang Yuan; Wei Hao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-28       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.